2011
DOI: 10.1007/s11011-010-9228-4
|View full text |Cite
|
Sign up to set email alerts
|

Erratum: Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice

Abstract: Springer apologizes for any confusion caused by the duplicate publication. T. Araki: DeceasedThe online version of the original article can be found at http://dx.doi.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…MPTP is an exogenous neurotoxin most commonly used to model PD in rodents and primates. In the presence of monoamine oxidase B in the brain, MPTP is converted into 1-methyl-4-phenyl- pyridinium (MPP + ), which can cause selective damage to DAn, inducing neuronal apoptosis and the occurrence and development of PD [22,23]. TH is a rate-limiting enzyme in catecholamine biosynthesis.…”
Section: Discussionmentioning
confidence: 99%
“…MPTP is an exogenous neurotoxin most commonly used to model PD in rodents and primates. In the presence of monoamine oxidase B in the brain, MPTP is converted into 1-methyl-4-phenyl- pyridinium (MPP + ), which can cause selective damage to DAn, inducing neuronal apoptosis and the occurrence and development of PD [22,23]. TH is a rate-limiting enzyme in catecholamine biosynthesis.…”
Section: Discussionmentioning
confidence: 99%